Intra-Cellular Therapies, Inc.
NOVEL METHODS
Last updated:
Abstract:
The present disclosure relates to pharmaceutical capsules comprising lumateperone, in free, or pharmaceutically acceptable salt form, optionally in combination with one or more additional therapeutic agents, processes for manufacture thereof and methods of use in the treatment or prophylaxis of disease.
Status:
Application
Type:
Utility
Filling date:
16 Jun 2020
Issue date:
1 Oct 2020